Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 49,301 | 59,733 | 21,006 | 0 | 0 |
| Cost of Goods | 3,341 | 2,453 | 1,202 | N/A | 0 |
| Gross Profit | 45,960 | 57,280 | 19,804 | N/A | N/A |
| Operating Expenses | 104,238 | 102,654 | 113,937 | 103,910 | 83,999 |
| Operating Income | -57,937 | -44,921 | -93,931 | -98,463 | -83,999 |
| Other Income | 4,407 | 5,002 | 6,546 | 4,141 | 4,562 |
| Pre-tax Income | -53,530 | -39,919 | -87,385 | -94,322 | -79,437 |
| Net Income Continuous | -53,530 | -39,919 | -87,385 | -94,322 | -79,437 |
| Net Income | $-53,530 | $-39,919 | $-87,385 | $-94,322 | $-79,437 |
| EPS Basic Total Ops | -0.72 | -0.54 | -1.18 | -1.45 | -1.27 |
| EPS Basic Continuous Ops | -0.72 | -0.54 | -1.18 | -1.45 | -1.27 |
| EPS Diluted Total Ops | -0.72 | -0.54 | -1.18 | -1.45 | -1.27 |
| EPS Diluted Continuous Ops | -0.72 | -0.54 | -1.18 | -1.45 | -1.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.54 | -1.18 | -1.44 | -1.27 |
| EBITDA(a) | $-57,059 | $-44,077 | $-93,202 | $-103,372 | $-83,505 |